Date:3/18/2009

also synergizes with a five-year effort by the Japanese Government and the PMDA to improve clinical trials conduct, which went into effect in 2007. As part of this effort, in September 2007, the Ministry of Health, Labor, and Welfare (MHLW) published a report entitled "Basic Principles on Global Clinical Trials," which detailed methods for harmonizing clinical study conduct between Japan and other countries. "Here, BBK can also offer assistance," commented Andrew Sacher, general counsel and key developer of the BBK Worldwide -- Osaka, G.K., initiative. "With its extensive range of recruitment tools and international experience -- previously unavailable from a company operating in East Asia -- BBK has the potential to be a catalyst for even greater industry growth, and to foster novel ideas for clinical trial enrollment initiatives."

About BBK Worldwide

Founded in 1983 by Joan F. Bachenheimer and Bonnie A. Brescia, BBK Worldwide is a patient recruitment and e-business solution company for the clinical R&D and product marketing segments of the pharmaceutical, biotechnology, and medical device industries. BBK has helped to accelerate time-to-market for new medicines and treatments by successfully supporting hundreds of clinical studies in more than 60 countries, and in all major therapeutic areas. Staffed by some of the industry's principal thought leaders, BBK continually contributes ideas that advance the clinical development cycle. (bbkworldwide.com)

'/>"/>

SOURCE BBK Worldwide Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3
Related biology technology :

1. Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBCs 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
2. Pathway for Biosimilars Act Protects Patients, Promotes Competition, Preserves Innovation and Creates Quality Jobs, Lilly Says
3. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
4. Biogenerics Legislation Provides Critical Pathway to Affordable Access for Patients with Chronic and Complex Conditions
5. Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
6. Proteon Therapeutics Completes $38M Equity Financing; Initiates Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients and Signs Option Agreement With Major Pharmaceutical Company
7. Oregon Health & Science University Knight Cancer Institute Enhances Patient Care With Monaco(R) Radiation Treatment Planning System
8. Mayo Clinic CEO Offers New Vision for Personalized Patient Care
9. Photos: Project Runways Tim Gunn Launches Addressing Psoriasis(TM) Campaign to Advocate That Patients Shouldnt Let Psoriasis Impact Personal Style
10. NPSF Issues New Universal Patient Compact During Patient Safety Awareness Week
11. Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients